Ryder Innovation Fund

The Ryder Innovation Fund is a $20m committed capital fund that invests in highly prospective early stage private Australian companies.

The Fund was registered as an Early Stage Venture Capital Limited Partnership with Innovation and Science Australia in 2018. The ESVCLP program is designed to encourage investment in early stage innovation via a tax efficient fund structure.

The Fund targets investments in companies that have been incorporated within the last 7 years, have assets of less than $50m with the majority of its assets within Australia, and an average annual turnover less than $3m for the 2 years prior to making the investment.

Key benefits of ESVCLPs include:

  • no income or capital gains tax on the disposal of eligible venture capital investments (EVCIs) and other income earned on EVCIs for limited partners and general partners who are Australian residents; and

  • a non-refundable carry-forward tax offset of up to 10% on contributions made at any time to an ESVCLP.


  • 4D Medical Ltd

    December 2019

    4-Dimensional lung imaging platform technology.

    Visit Website
  • Tetratherix Pty Ltd

    March 2020

    Novel injectable class of polymer peptide scaffolds.

    Visit Website
  • PlayHQ

    February 2021

    Leading edge grassroots sports technology platform

    Visit Website

©Ryder Capital. All Rights Reserved. Website by Geen
It appears you're using an old version of Internet Explorer which is no longer supported, for safer and optimum browsing experience please upgrade your browser.